Third, supply side switching is only possible for players that have already the
capabilities to manufacture GM and non-GM produced lactase. The Commission notes the Parties’ argument that the same equipment is used for the production of GM and non-GM produced lactase meaning that it is possible to relatively quickly switch production between GM and non-GM produced lactases.69 However, for a manufacturer to be able to switch between batches of GM and non-GM produced lactase, it must already have developed and have access to the production technology and know-how to produce both. At the moment, out of the 6 lactase manufacturers worldwide, only DSM manufactures both GM produced and nonGM produced lactase. Moreover, developing such capacities seem to be complex and time consuming. For instance, once Chr. Hansen decided to develop its own GM produced lactase in [date], it needed close to [time period] to develop a lactase enzyme and a production host.70